Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception.

Katsuyama S, Mizoguchi H, Kuwahata H, Komatsu T, Nagaoka K, Nakamura H, Bagetta G, Sakurada T, Sakurada S.

Eur J Pain. 2013 May;17(5):664-75. doi: 10.1002/j.1532-2149.2012.00242.x. Epub 2012 Nov 9.

PMID:
23138934
2.

The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.

da Fonseca Pacheco D, Klein A, de Castro Perez A, da Fonseca Pacheco CM, de Francischi JN, Duarte ID.

Br J Pharmacol. 2008 Jul;154(5):1143-9. doi: 10.1038/bjp.2008.175. Epub 2008 May 12.

3.

Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.

McGaraughty S, Honore P, Wismer CT, Mikusa J, Zhu CZ, McDonald HA, Bianchi B, Faltynek CR, Jarvis MF.

Br J Pharmacol. 2005 Sep;146(2):180-8.

4.

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP Jr.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3093-8. Epub 2005 Feb 10.

5.

Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.

Rahn EJ, Zvonok AM, Makriyannis A, Hohmann AG.

AAPS J. 2010 Jun;12(2):147-57. doi: 10.1208/s12248-009-9170-8. Epub 2010 Feb 2.

6.

Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.

Pacheco Dda F, Klein A, Perez AC, Pacheco CM, de Francischi JN, Reis GM, Duarte ID.

Br J Pharmacol. 2009 Sep;158(1):225-31. doi: 10.1111/j.1476-5381.2009.00310.x. Epub 2009 Jul 7.

7.

Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.

Zhang GH, Min SS, Seol GH, Lee KS, Han H, Kim YI, Han HC.

Pain. 2009 Jun;143(3):233-7. doi: 10.1016/j.pain.2009.03.007. Epub 2009 Apr 9.

PMID:
19361925
8.

Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.

Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y.

Neurosci Lett. 1994 Jan 3;165(1-2):141-3.

PMID:
8015716
9.

Effects of neuropeptide FF system on CB₁ and CB₂ receptors mediated antinociception in mice.

Fang Q, Han ZL, Li N, Wang ZL, He N, Wang R.

Neuropharmacology. 2012 Feb;62(2):855-64. doi: 10.1016/j.neuropharm.2011.09.013. Epub 2011 Sep 19.

PMID:
21945715
10.

Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.

Mizoguchi H, Kon-No T, Watanabe H, Watanabe C, Yonezawa A, Sato T, Sakurada T, Sakurada S.

Peptides. 2013 Dec;50:139-44. doi: 10.1016/j.peptides.2013.10.003. Epub 2013 Oct 12.

PMID:
24126280
11.

Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.

Heyman JS, Jiang Q, Rothman RB, Mosberg HI, Porreca F.

Eur J Pharmacol. 1989 Oct 4;169(1):43-52.

12.

Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism.

Sakurada T, Mizoguchi H, Kuwahata H, Katsuyama S, Komatsu T, Morrone LA, Corasaniti MT, Bagetta G, Sakurada S.

Pharmacol Biochem Behav. 2011 Jan;97(3):436-43. doi: 10.1016/j.pbb.2010.09.020. Epub 2010 Oct 13.

PMID:
20932858
13.

Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.

Matsumoto K, Hatori Y, Murayama T, Tashima K, Wongseripipatana S, Misawa K, Kitajima M, Takayama H, Horie S.

Eur J Pharmacol. 2006 Nov 7;549(1-3):63-70. Epub 2006 Aug 16.

PMID:
16978601
14.

Relative contribution of peripheral versus central opioid receptors to antinociception.

Labuz D, Mousa SA, Schäfer M, Stein C, Machelska H.

Brain Res. 2007 Jul 30;1160:30-8. Epub 2007 Jun 2.

PMID:
17599812
15.

Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.

Bedini A, Baiula M, Gentilucci L, Tolomelli A, De Marco R, Spampinato S.

Peptides. 2010 Nov;31(11):2135-40. doi: 10.1016/j.peptides.2010.08.005. Epub 2010 Aug 14.

PMID:
20713109
17.

Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.

Tsai RY, Tai YH, Tzeng JI, Cherng CH, Yeh CC, Wong CS.

Neuroscience. 2009 Dec 1;164(2):435-43. doi: 10.1016/j.neuroscience.2009.08.015. Epub 2009 Aug 12.

PMID:
19682558
18.
19.

Beta-caryophyllene is a dietary cannabinoid.

Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A.

Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9099-104. doi: 10.1073/pnas.0803601105. Epub 2008 Jun 23.

20.

Supplemental Content

Support Center